“confirms it is in advanced discussions with Neuphoria Therapeutics Inc. ("Neuphoria") regarding a potential reverse merger transaction, whereby Scancell would acquire Neuphoria via an all-share transaction”
I believe the bid that was received by Scancell was only for one of the platforms (either Scib or Modi)
And at the time there was disagreement in the board room about splitting the company up for short term gains instead of letting the data mature and vastly increasing its value.